NS

Nature's Sunshine Products, Inc.

NATRยทNASDAQ

$19.90

-4.5%
Consumer DefensivePackaged Foods

Nature's Sunshine Products, Inc., a natural health and wellness company, primarily manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision. The company also provides immunity, cardiovascular, and digestive products; and personal care products, such as oils and lotions, aloe vera gels, herbal shampoos, herbal skin treatment, toothpaste, and skin cleansers, as well as weight management products. It offers its products under the Nature's Sunshine and Synergy WorldWide brands through a sales force of independent consultants. The company was founded in 1972 and is headquartered in Lehi, Utah.

At a Glance

Live Snapshot
Market Cap$349.94M
EPS1.0800
P/E Ratio18.43
Earnings Date07/30/2026

Intrinsic Alpha Methodology

Thesis Lenses

Signal ยท Driver ยท Risk

Signal

High confidence

Valuation multiple is mid-range (P/E 18.4).

Valuation inputs: P/E 18.4, earnings yield +5.4%, momentum -4.5%.

If multiples stay elevated while momentum fades, downside repricing risk rises.

Driver

High confidence

Return profile is acceptable (ROE +12.1%, ROIC +9.1%).

Profitability stack: net margin +4.1%, ROE +12.1%, ROIC +9.1%.

Quality deterioration often appears in margins before it shows up in headline EPS.

Risk

High confidence

Risk profile is balanced but has notable pressure points to monitor.

Risk factors: liabilities/assets +38.1%, momentum -4.5%, net margin +4.1%.

Higher leverage with weak momentum and thin margins can amplify drawdown severity.

n

Nature's Sunshine Products, Inc. Market vs Earnings Trajectory

NATR ยท NASDAQ
Current Price
$19.90
EPS (TTM)
$1.11

Performance Analysis

EPS Growth

+45.5%

Strong earnings growth indicates robust business expansion and improving profitability.

Price-EPS Relationship

Aligned

Stock price is moving in line with earnings growthโ€”a healthy sign of fundamental-driven valuation.

Stock Price Change

+38.1%

Over the 1Y period, stock price has increased by 38.1%.

P/E Ratio (TTM)

18.4x

Moderate P/E ratio suggests fair market valuation relative to earnings.

Key Insight

Strong earnings growth (+45.5%) is outpacing price appreciation (+38.1%), potentially indicating an attractive entry point as the market may not have fully recognized the improving fundamentals.

NS

Nature's Sunshine Products, Inc. Fair Value Envelope

NATR ยท NASDAQ

Our analysis suggests that NATR has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $19.9, this represents a potential HIDDEN relative to our calculated worth for Nature's Sunshine Products, Inc..

Intrinsic Value
Current Price: $19.9
3Y-5500.0%
5Y-1.0%
10Y+882.0%
3Y+14.0%
5Y+25.0%
10Y+41.0%
3Y-5105.0%
5Y-9.0%
10Y+813.0%
3Y+4875.0%
5Y-6.0%
10Y+934.0%
3Y-517.0%
5Y-12.0%
10Y-455.0%
3Y+14.0%
5Y+5.0%
10Y+27.0%
NS

Nature's Sunshine Products, Inc. Profit Bridge

NATR ยท NASDAQ
Revenue480.14M
Cost of Goods Sold (146.26M)
Gross Profit333.88M
Operating Expenses (309.14M)
Operating Income24.74M
Interest Expense (98.00K)
Other Income/Expense5.07M
Pretax Income29.81M
Income Tax (9.36M)
Net Income19.52M
Net Income
19.52M

Profitability Analysis

Gross Margin

69.5%

Exceptional pricing power and cost management. The company retains over half of revenue after direct costs.

Operating Margin

5.2%

Acceptable margins but limited operational leverage. Operating expense control is important.

Net Profit Margin

4.1%

Minimal profitability after all expenses. Limited financial flexibility for reinvestment or shareholder returns.

Effective Tax Rate

31.4%

Higher tax burden may reflect limited tax optimization or operations in high-tax jurisdictions.

Profitability Insight

Margin squeeze alert: Healthy gross margins but weak operating margins suggest excessive operating expenses. Cost optimization could unlock significant value.

69.54%
Gross Profit Margin
-3%
3Y-2.0%
5Y-6.0%
10Y-5.0%
5.15%
Operating Profit Margin
17%
3Y+34.0%
5Y-8.0%
10Y+75.0%
4.07%
Net Profit Margin
140%
3Y-4500.0%
5Y-27.0%
10Y+548.0%
12.08%
Return on Equity
144%
3Y-4528.0%
5Y-12.0%
10Y+641.0%
7.48%
Return on Assets
134%
3Y-4505.0%
5Y-13.0%
10Y+618.0%
9.13%
Return on Invested Capital
90%
3Y+2536.0%
5Y-20.0%
10Y+1804.0%
N

Nature's Sunshine Products, Inc. Cash Conversion Engine

NATR ยท NASDAQ
Net Income0.00
Depreciation & Amortization0.00
Stock-Based Compensation0.00
Change in Working Capital-3.09M
Others38.41M
Capital Expenditures-6.48M
Free Cash Flow28.84M

Cash Flow Quality Analysis

CapEx Intensity

18.3%

Asset-light business model. Low capital requirements leave more cash available for shareholders and growth investments.

FCF Growth Trend

+101.3%

Strong FCF growth demonstrates improving cash generation and business momentum. Positive signal for sustainability.

Working Capital Impact

-$3.09M

Minimal working capital impact on FCF. Changes in operating assets and liabilities well-managed.

n

Nature's Sunshine Products, Inc. Funding & Solvency Profile

NATR ยท NASDAQ
Cash & Cash Equivalents87.58M
Net Receivables12.55M
Inventory67.13M
Other Current Assets11.33M
Total Current Assets179 M
Property, Plant & Equipment51.79M
Goodwill & Intangible Assets0.00
Long-Term Investments1.27M
Other Non-Current Assets10.40M
Total Non-Current Assets63 M
Total Assets
261.46M

Financial Health Analysis

Current Ratio

2.50x

Excellent liquidity position. The company can easily cover its short-term obligations with substantial cushion.

Debt-to-Equity Ratio

0.57x

Balanced capital structure with moderate leverage. Equity exceeds debt, suggesting healthy financial stability.

Working Capital

107 M

Strong working capital position provides significant operational flexibility and financial cushion.

Asset Composition

68% Current

Asset-light business model with high liquidity. Majority of assets are easily convertible to cash.

Financial Health Insight

Strong financial foundation: Excellent liquidity combined with conservative leverage suggests the company is well-positioned to weather economic uncertainties and fund growth opportunities.

n

Nature's Sunshine Products, Inc. Street Expectations Map

NATR ยท NASDAQ

Wall Street analysts project that NATR stock may rise significantly over the coming 12 months. The consensus 1-year price target stands at 37.00, with estimates ranging from a low of 37.00 to a high of 37.00.

Lowest Target
37.00
85.93%
Consensus Target
37.00
85.93%
Highest Target
37.00
85.93%

The consensus 1-year price target stands at 37.00, with estimates ranging from a low of 37.00 to a high of 37.00.

Analyst Consensus Analysis

Upside Potential

+85.9%

Substantial upside potential. Analysts see significant value gap, suggesting the stock may be materially undervalued at current levels.

Analyst Agreement

0.0% spread

High analyst agreement. Narrow target range indicates strong consensus on valuation, suggesting clear investment thesis and predictable outlook.

Analyst Conviction

Very High

Strong buy conviction: High upside with tight consensus suggests compelling investment opportunity backed by analyst confidence.

Market Sentiment Insight

Rare opportunity: Exceptional upside potential with strong analyst consensus creates a compelling setup. The combination of significant price target premium and tight agreement suggests high-conviction undervaluation that may attract institutional capital.

n

Nature's Sunshine Products, Inc. Insider Positioning

NATR ยท NASDAQ

During the last 12 months, insiders have sold $35.05M worth of NATR shares, with no buying activity reported.

3 Months

Bought

0

0.00

Sold

50.9K

1.21M

Net Activity

-1.2M

-$1.21M

3-6 Months

Bought

0

0.00

Sold

1.7K

37.89K

Net Activity

-38K

-$38K

6-9 Months

Bought

0

0.00

Sold

18.9K

383.13K

Net Activity

-383K

-$383K

9-12 Months

Bought

0

0.00

Sold

2.9M

33.41M

Net Activity

-33.4M

-$33.41M

Top Buyers

No buying activity

Top Sellers

1
SFP(CL

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

10 Percent Owner

2.9M sharesโ€ข1 transactions

$32.71M

2
YBJ

Yates Bryant J

Officer: Evp & President, Europe

32.6K sharesโ€ข5 transactions

$701K

3
NDC

Norman Daniel C

Officer: Evp & President, Asia

26.0K sharesโ€ข3 transactions

$584K

4
BNG

Brower Nathan G

Officer: Evp, General Counsel

27.3K sharesโ€ข4 transactions

$529K

5
LJD

Lanoy Jonathan David

Officer: Svp, Chief Accounting Officer

14.3K sharesโ€ข4 transactions

$289K

Insider Activity Analysis

Net Insider Sentiment

Bearish

Strong bearish signal with $35.05M net selling. Heavy insider selling may indicate concerns about valuation or near-term prospects.

Buy/Sell Ratio

0.00:1

Very poor ratio. Heavy selling with minimal buying suggests insiders may be concerned about valuation or outlook.

Recent Trend (3 Months)

$1.21M

Heavy recent selling activity. Recent insider sales notably exceed purchasesโ€”may warrant investigation into company developments.

Insider Participation

High Selling

5 insider sellers vs. 0 buyers. Widespread selling across multiple insiders may signal concerns.

Insider Activity Insight

Multiple red flags: Heavy selling, numerous sellers, and continued recent selling create a concerning pattern. Investigate fundamental drivers and consider whether company guidance or industry conditions have deteriorated.

0.00%
Dividend Yield
3Y-
5Y-100.0%
10Y-100.0%
ย 

natr Dividend History

NATR
10Y CAGR +35%
Latest $1
Annual $1
5 year growth trend
Last Period: +900%